There is no single mechanism. The formula groups its ingredients around four areas commonly targeted in cognitive-support products: acetylcholine availability, brain cell membrane structure, cerebral circulation, and mitochondrial energy in neurons.
Everything below explains why an ingredient was included and what research exists on that ingredient in isolation. None of it establishes what the finished capsule will do for any individual. That distinction is the whole of the honesty question on a page like this.
Alpha-GPC is a highly bioavailable choline compound that crosses the blood-brain barrier. Choline is the precursor the body uses to make acetylcholine, the neurotransmitter most closely tied to learning and memory encoding.
Of the mechanisms in this formula, this is the most straightforward: supply a building block and let the body use it. It is not the same as a prescription drug that blocks acetylcholine breakdown, and it should not be combined with one without medical supervision.
Phosphatidylserine is a phospholipid found naturally in the membranes of brain cells. N-Acetyl-L-Carnitine is a brain-penetrating carnitine form included for mitochondrial energy production in neurons.
Both are widely used in cognitive formulas. Much of the phosphatidylserine research uses combination products rather than the isolated compound, which makes its individual contribution difficult to separate out.
Ginkgo Biloba is associated in research with cerebral blood flow. What has not been established is that improved circulation produces measurable memory improvement in healthy adults.
The most useful evidence here runs against the marketing. The NIH-funded Ginkgo Evaluation of Memory study followed more than 3,000 older adults and found ginkgo ineffective at preventing dementia; further analysis of the same data found it did not slow cognitive decline either. The National Center for Complementary and Integrative Health states this plainly on its ginkgo page.
Bacopa Monnieri carries the most direct human research on memory in this formula. Randomised trials have generally run 8 to 12 weeks at doses around 300 to 450 mg per day, with modest improvements in delayed recall reported in some.
Bacopa is slow. That is why claims of results in two or three weeks should be treated with suspicion, and why a single bottle is not long enough to judge a product built around it.
St John's wort is included on the reasoning that low mood and anxiety worsen concentration. It has reasonable evidence for mild-to-moderate depression — and it is the reason a large group of people cannot take this product at all.
The interaction list is long and includes medicines commonly taken by the age group this supplement targets. It is set out in full on the safety page, and it is worth reading before the pricing table rather than after.